Sponsor
Australian local sponsor
For clinical trials conducted in Australia, the sponsor role must be held by an Australian entity. Clintrail acts as that Australian sponsor for overseas companies entering Australia without setting up a subsidiary first.
The arrangement needs to be precise: Clintrail holds the Australian sponsor role, while the overseas company keeps product ownership, global program control, and the broader development strategy.
Definition
What "Australian local sponsor" means.
When we say Australian local sponsor, we mean the Australian entity that takes the trial sponsor role for the Australian study.
This is not just an administrative contact point or mailing address. The Australian sponsor is the entity responsible for the sponsor role in Australia, including the relevant Australian regulatory, governance, oversight, and safety-reporting interfaces.
Technical role
What the Australian sponsor role covers
The exact responsibility split should be documented for each study, but the sponsor role is a real accountability position under Australian clinical trial requirements.
The sponsor must be an Australian entity.
For Australian clinical trials, the sponsor role must be held locally. Clintrail provides that Australian sponsor entity for eligible studies.
The Australian sponsor is the TGA-facing sponsor.
For studies involving unapproved therapeutic goods, the Australian sponsor is responsible for the applicable CTN notification or CTA application process, and for variations or completion notices where required.
Sponsor duties can be allocated, but responsibility does not disappear.
Operational tasks may sit with the overseas company, sites, investigators, or other providers. The Australian sponsor still needs appropriate oversight of delegated sponsor functions.
Safety monitoring and reporting arrangements must be clear.
The sponsor role includes ensuring safety responsibilities are allocated, monitored, and reported through the correct Australian pathways where required.
When needed
When sponsors usually need a local sponsor
- An overseas sponsor is opening its first Australian study.
- Australia is being added to an existing global program.
- A medical device, diagnostics, biotech, or pharma company needs an Australian sponsor for a local study.
- The sponsor wants to avoid the time and cost of establishing an Australian subsidiary before startup.
- Regulatory and operations teams want the Australian sponsor responsibilities defined early.
Service scope
What Clintrail does
- Acting as the Australian trial sponsor for the Australian study.
- Submitting and maintaining the Australian CTN or CTA, where that pathway applies.
- Confirming the Australian sponsor responsibility split before startup.
- Maintaining oversight of sponsor functions allocated to sites, the overseas company, and other service providers.
- Supporting Australian sponsor communications with TGA, HRECs, approving authorities, investigators, and sites.
Role split
How Clintrail works with the overseas company
Clintrail as Australian sponsor
Holds the sponsor role in Australia, submits or maintains the applicable CTN or CTA, keeps the Australian sponsor responsibility matrix clear, and maintains oversight of sponsor functions for the Australian study.
Overseas company
Keeps product ownership, IP, global development strategy, protocol leadership, study funding, global safety information, and broader program decisions.
Sites, investigators, and approving authorities
Handle site-level conduct, participant care, ethics and governance processes, and local approvals in line with their own responsibilities and agreements.
Operating model
Define the sponsor role before Australian startup begins.
Study and pathway review
Clintrail reviews the proposed Australian study, product type, intended pathway, site model, timing, and local sponsor requirements.
Responsibility matrix
Before appointment, the parties define who is responsible for CTN or CTA activity, safety reporting inputs, insurance, contracts, product supply, monitoring, records, and study governance.
Sponsor appointment
Clintrail is appointed as the Australian sponsor for the defined study scope, with the overseas company funding and supporting the Australian study under the agreed structure.
Australian sponsor oversight
During startup and conduct, Clintrail maintains the Australian sponsor role, supports required sponsor interactions, and keeps responsibility boundaries visible as the study changes.
Responsibility matrix
What Clintrail does, and what remains with you
The exact split is documented for each clinical trial, but overseas sponsor teams usually need a clear view of these responsibility areas early.
| Area | Clintrail | Overseas sponsor |
|---|---|---|
| Australian sponsor role | Holds the Australian sponsor role for the defined clinical trial scope. | Keeps global sponsor strategy and program leadership. |
| Product and protocol | Reviews the Australian sponsor implications of the product type, pathway, and protocol. | Owns the product, protocol strategy, IP, funding, and global development plan. |
| CTN / CTA pathway | Manages the Australian sponsor side of the applicable CTN notification or CTA application process. | Provides product, protocol, safety, and operational information needed for the Australian pathway. |
| Safety and governance | Maintains oversight of Australian sponsor responsibilities and agreed safety-reporting interfaces. | Provides global safety information and supports agreed reporting, records, and governance processes. |
Boundary
Local sponsorship is not a transfer of the global program.
Clintrail assumes the Australian sponsor role for the defined study scope. The overseas company remains the product owner and continues to direct the wider development program.
Not replaced
What the arrangement does not replace
- Clintrail does not become the global product owner or marketing authorisation holder.
- Clintrail does not replace the overseas company's clinical, regulatory, legal, tax, or commercial advisers.
- Clintrail does not replace HREC review, site governance, investigator responsibilities, or site-level participant care.
- Clintrail does not remove the need for insurance, indemnity, contracts, study records, and safety reporting processes to be set up correctly.
Scenarios
Typical situations
First Australian study
The sponsor wants to test Australia as a trial jurisdiction without establishing a separate Australian company before the first study is underway.
Regional expansion
Australia is being added to a wider global program and the Australian sponsor role needs to be held locally without changing the wider sponsor model.
Cost-controlled entry
The sponsor wants the Australian sponsor role covered without adding local company setup, governance, accounting, tax, and maintenance work before the study is justified.
Next step
Need an Australian local sponsor?
Send through a short description of the study and your planned Australian activity. We will review it and get back to you soon.